Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1340401
European Journal of Endocrinology, Vol 134, Issue 4, 401-402
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneyer, A. L
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schneyer, A. L

Measurement of activin in physiological fluids

Alan L Schneyer

To understand the complex biochemistry and physiology of activin and inhibin requires the development and validation of a number of specific immunoassays. The importance of this endeavour is signified by the tremendous effort spent by a number of laboratories to develop such assays over the past decade. Based on the deduced amino acid sequence obtained when the inhibin-{alpha} and -βAB genes were cloned (1), RIAs using synthetic peptides were developed that were quite useful in animal studies (2). Human applications required the further development of a heterologous RIA using purified bovine inhibin as antigen, the result of which was an assay that allowed the charting of inhibin's physiology in a number of settings (3). It was soon discovered that multiple forms of inhibin and its free {alpha}-subunit exist in physiological fluids (4–7) and these free {alpha}-subunits cross-react in the existing RIAs, thereby complicating interpretation of results (7).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.